ARTAÇ, M. Et Al. 2017. Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab. JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.2 , 176-180.

ARTAÇ, M., UYSAL, M., KARAAĞAÇ, M., Korkmaz, L., Er, Z., Guler, T., ... Boruban, M. C.(2017). Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab. JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.2, 176-180.

ARTAÇ, MEHMET Et Al. "Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab," JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.2, 176-180, 2017

ARTAÇ, MEHMET Et Al. "Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab." JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.2, pp.176-180, 2017

ARTAÇ, M. Et Al. (2017) . "Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab." JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.2, pp.176-180.

@article{article, author={MEHMET ARTAÇ Et Al. }, title={Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab}, journal={JOURNAL OF GASTROINTESTINAL CANCER}, year=2017, pages={176-180} }